这是一篇来自已证抗体库的有关
人类 FasL (FasL) 的综述,是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合FasL 抗体。
FasL 同义词: ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A
赛默飞世尔
小鼠 单克隆(NOK-1) | | 赛默飞世尔FasL抗体(eBioscience, NOK-1)被用于被用于流式细胞仪在人类样本上 (图 4b). BMC Immunol (2020) ncbi |
小鼠 单克隆(NOK-1) | | 赛默飞世尔FasL抗体(eBioscience, NOK-1)被用于被用于流式细胞仪在人类样本上 (图 2). Sci Rep (2016) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(NOK-1) | | 圣克鲁斯生物技术FasL抗体(Santa Cruz Biotechnology, sc-19681)被用于被用于免疫印迹在大鼠样本上浓度为1:200 (图 5c). Int J Nanomedicine (2020) ncbi |
BioLegend
小鼠 单克隆(NOK-1) | | BioLegendFasL抗体(BioLegend, NOK-1)被用于被用于流式细胞仪在人类样本上 (图 3d). Oncoimmunology (2017) ncbi |
小鼠 单克隆(NOK-1) | | BioLegendFasL抗体(BioLegen d, 306407)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
小鼠 单克隆(NOK-1) | | BioLegendFasL抗体(biolegend, NOK-1)被用于被用于抑制或激活实验在人类样本上 (图 4). Leuk Res (2015) ncbi |
安迪生物R&D
小鼠 单克隆(100419) | | 安迪生物R&DFasL抗体(R&D Systems, MAB126)被用于被用于抑制或激活实验在人类样本上 (图 s2). Cell Death Differ (2017) ncbi |
小鼠 单克隆(100419) | | 安迪生物R&DFasL抗体(R&D Systems, MAB126)被用于被用于抑制或激活实验在人类样本上 (图 s2a). Cell Death Dis (2017) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆 | | 艾博抗(上海)贸易有限公司FasL抗体(Abcam, ab15285)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Onco Targets Ther (2016) ncbi |
伯乐(Bio-Rad)公司
小鼠 单克隆(14C2) | | 伯乐(Bio-Rad)公司FasL抗体(AbD Serotec, 14C2)被用于被用于流式细胞仪在人类样本上 (图 s3). PLoS Pathog (2016) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司FasL抗体(Cell Signaling, 4273)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3j). Nat Commun (2017) ncbi |
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司FasL抗体(Cell Signaling Tech, 4273S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi |
碧迪BD
小鼠 单克隆(NOK-1) | | 碧迪BDFasL抗体(BD Biosciences, Nok-1)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2016) ncbi |
小鼠 单克隆(G247-4) | | 碧迪BDFasL抗体(BD Pharmingen, G247-4)被用于被用于免疫细胞化学在人类样本上 (图 5). Photochem Photobiol (2015) ncbi |
小鼠 单克隆(NOK-1) | | 碧迪BDFasL抗体(BD Pharmingen, 556373)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在大鼠样本上. Toxicol Lett (2015) ncbi |
Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D,
et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23
pubmed 出版商
Lin Y, Huang X, Chang K, Liao K, Tsai N. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine. 2020;15:749-760
pubmed 出版商
Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586
pubmed 出版商
Villar V, Nguyen T, Delcroix V, Terés S, Bouchecareilh M, Salin B,
et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 2017;8:14124
pubmed 出版商
Tanzer M, Khan N, Rickard J, Etemadi N, Lalaoui N, Spall S,
et al. Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death Differ. 2017;24:481-491
pubmed 出版商
Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535
pubmed 出版商
Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592
pubmed
Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A,
et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832
pubmed 出版商
Liu Y, Wang Y, Ding G, Yang T, Yao L, Hua J,
et al. JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway. Onco Targets Ther. 2016;9:4425-33
pubmed 出版商
Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H,
et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296
pubmed 出版商
Cheng C, Jiao J, Qian Y, Guo X, Huang J, Dai M,
et al. Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells. Mol Med Rep. 2016;13:3763-70
pubmed 出版商
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商
Salva K, Wood G. Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma. Photochem Photobiol. 2015;91:1444-51
pubmed 出版商
Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59
pubmed 出版商
Difranco K, Johnson Farley N, Bertino J, Elson D, Vega B, Belinka B,
et al. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. Leuk Res. 2015;39:649-56
pubmed 出版商